RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
33.66
-4.53 (-11.86%)
At close: Dec 20, 2024, 4:00 PM
33.70
+0.04 (0.12%)
After-hours: Dec 20, 2024, 7:59 PM EST
RxSight Market Cap
RxSight has a market cap or net worth of $1.36 billion as of December 20, 2024. Its market cap has increased by 10.74% in one year.
Market Cap
1.36B
Enterprise Value
1.13B
1-Year Change
10.74%
Ranking
Category
Stock Price
$33.66
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $1.36B, an increase of 219.71%. That is a compound annual growth rate of 40.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 1.36B | -6.18% |
Dec 29, 2023 | 1.45B | 311.68% |
Dec 30, 2022 | 351.23M | 14.14% |
Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fortrea Holdings | 1.66B |
Arcutis Biotherapeutics | 1.65B |
10x Genomics | 1.65B |
Clover Health Investments | 1.60B |
Teladoc Health | 1.54B |
BioCryst Pharmaceuticals | 1.53B |
Evotec SE | 1.53B |
Travere Therapeutics | 1.51B |